Filip Janku, MD, PhD | Authors


The Importance of Urine Tests for Mutation Detection

June 17, 2014

Filip Janku, MD, PhD, assistant professor, Department of Investigational Cancer Therapeutics, University of Texas, MD Anderson Cancer Center, discusses the importance of having a urine test to detect for cancer mutations.

Sirolimus and Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma

June 02, 2014

Filip Janku, MD, PhD, discusses a trial presented at the 2014 ASCO Annual Meeting looking at the activity of the mTOR inhibitor sirolimus and HDAC inhibitor vorinostat in heavily pretreated patients with refractory Hodgkin lymphoma.